Literature DB >> 25117714

Most human non-GCIMP glioblastoma subtypes evolve from a common proneural-like precursor glioma.

Tatsuya Ozawa1, Markus Riester2, Yu-Kang Cheng2, Jason T Huse3, Massimo Squatrito4, Karim Helmy5, Nikki Charles5, Franziska Michor6, Eric C Holland7.   

Abstract

To understand the relationships between the non-GCIMP glioblastoma (GBM) subgroups, we performed mathematical modeling to predict the temporal sequence of driver events during tumorigenesis. The most common order of evolutionary events is 1) chromosome (chr) 7 gain and chr10 loss, followed by 2) CDKN2A loss and/or TP53 mutation, and 3) alterations canonical for specific subtypes. We then developed a computational methodology to identify drivers of broad copy number changes, identifying PDGFA (chr7) and PTEN (chr10) as driving initial nondisjunction events. These predictions were validated using mouse modeling, showing that PDGFA is sufficient to induce proneural-like gliomas and that additional NF1 loss converts proneural to the mesenchymal subtype. Our findings suggest that most non-GCIMP mesenchymal GBMs arise as, and evolve from, a proneural-like precursor.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25117714      PMCID: PMC4143139          DOI: 10.1016/j.ccr.2014.06.005

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  55 in total

1.  The neighbor-joining method: a new method for reconstructing phylogenetic trees.

Authors:  N Saitou; M Nei
Journal:  Mol Biol Evol       Date:  1987-07       Impact factor: 16.240

2.  A mathematical framework to determine the temporal sequence of somatic genetic events in cancer.

Authors:  Camille Stephan-Otto Attolini; Yu-Kang Cheng; Rameen Beroukhim; Gad Getz; Omar Abdel-Wahab; Ross L Levine; Ingo K Mellinghoff; Franziska Michor
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-23       Impact factor: 11.205

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.

Authors:  Tatsuya Ozawa; Cameron W Brennan; Lu Wang; Massimo Squatrito; Takashi Sasayama; Mitsutoshi Nakada; Jason T Huse; Alicia Pedraza; Satoshi Utsuki; Yoshie Yasui; Adesh Tandon; Elena I Fomchenko; Hidehiro Oka; Ross L Levine; Kiyotaka Fujii; Marc Ladanyi; Eric C Holland
Journal:  Genes Dev       Date:  2010-10-01       Impact factor: 11.361

5.  Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation.

Authors:  M Hermansson; M Nistér; C Betsholtz; C H Heldin; B Westermark; K Funa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

6.  Pten haploinsufficiency accelerates formation of high-grade astrocytomas.

Authors:  Chang-Hyuk Kwon; Dawen Zhao; Jian Chen; Sheila Alcantara; Yanjiao Li; Dennis K Burns; Ralph P Mason; Eva Y-H P Lee; Hong Wu; Luis F Parada
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

7.  A differentiation-based phylogeny of cancer subtypes.

Authors:  Markus Riester; Camille Stephan-Otto Attolini; Robert J Downey; Samuel Singer; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2010-05-06       Impact factor: 4.475

8.  Modeling Adult Gliomas Using RCAS/t-va Technology.

Authors:  Dolores Hambardzumyan; Nduka M Amankulor; Karim Y Helmy; Oren J Becher; Eric C Holland
Journal:  Transl Oncol       Date:  2009-05       Impact factor: 4.243

9.  Identification of global alteration of translational regulation in glioma in vivo.

Authors:  Karim Helmy; John Halliday; Elena Fomchenko; Manu Setty; Ken Pitter; Christoph Hafemeister; Eric C Holland
Journal:  PLoS One       Date:  2012-10-03       Impact factor: 3.240

10.  Recruited cells can become transformed and overtake PDGF-induced murine gliomas in vivo during tumor progression.

Authors:  Elena I Fomchenko; Joseph D Dougherty; Karim Y Helmy; Amanda M Katz; Alexander Pietras; Cameron Brennan; Jason T Huse; Ana Milosevic; Eric C Holland
Journal:  PLoS One       Date:  2011-07-06       Impact factor: 3.240

View more
  175 in total

1.  Putting Glioblastoma in Its Place: IRF3 Inhibits Invasion.

Authors:  Siobhan S Pattwell; Eric C Holland
Journal:  Trends Mol Med       Date:  2017-07-31       Impact factor: 11.951

2.  Collateral Lethality: A new therapeutic strategy in oncology.

Authors:  Florian L Muller; Elisa A Aquilanti; Ronald A DePinho
Journal:  Trends Cancer       Date:  2015-11-01

Review 3.  Glycosylation alterations in lung and brain cancer.

Authors:  Hassan Lemjabbar-Alaoui; Andrew McKinney; Yi-Wei Yang; Vy M Tran; Joanna J Phillips
Journal:  Adv Cancer Res       Date:  2015-02-07       Impact factor: 6.242

4.  Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.

Authors:  Hideki Murata; Koji Yoshimoto; Ryusuke Hatae; Yojiro Akagi; Masahiro Mizoguchi; Nobuhiro Hata; Daisuke Kuga; Akira Nakamizo; Toshiyuki Amano; Tetsuro Sayama; Koji Iihara
Journal:  J Neurooncol       Date:  2015-08-14       Impact factor: 4.130

5.  Spatiotemporal genomic architecture informs precision oncology in glioblastoma.

Authors:  Jin-Ku Lee; Jiguang Wang; Jason K Sa; Erik Ladewig; Hae-Ock Lee; In-Hee Lee; Hyun Ju Kang; Daniel S Rosenbloom; Pablo G Camara; Zhaoqi Liu; Patrick van Nieuwenhuizen; Sang Won Jung; Seung Won Choi; Junhyung Kim; Andrew Chen; Kyu-Tae Kim; Sang Shin; Yun Jee Seo; Jin-Mi Oh; Yong Jae Shin; Chul-Kee Park; Doo-Sik Kong; Ho Jun Seol; Andrew Blumberg; Jung-Il Lee; Antonio Iavarone; Woong-Yang Park; Raul Rabadan; Do-Hyun Nam
Journal:  Nat Genet       Date:  2017-03-06       Impact factor: 38.330

6.  Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma.

Authors:  Forrest M Kievit; Kui Wang; Tatsuya Ozawa; Aria W Tarudji; John R Silber; Eric C Holland; Richard G Ellenbogen; Miqin Zhang
Journal:  Nanomedicine       Date:  2017-06-11       Impact factor: 5.307

Review 7.  The evolution of tumour phylogenetics: principles and practice.

Authors:  Russell Schwartz; Alejandro A Schäffer
Journal:  Nat Rev Genet       Date:  2017-02-13       Impact factor: 53.242

8.  Epigenetic Regulation of ZBTB18 Promotes Glioblastoma Progression.

Authors:  Vita Fedele; Fangping Dai; Anie P Masilamani; Dieter H Heiland; Eva Kling; Ana M Gätjens-Sanchez; Roberto Ferrarese; Leonardo Platania; Doostkam Soroush; Hyunsoo Kim; Sven Nelander; Astrid Weyerbrock; Marco Prinz; Andrea Califano; Antonio Iavarone; Markus Bredel; Maria S Carro
Journal:  Mol Cancer Res       Date:  2017-05-16       Impact factor: 5.852

9.  In vitro modeling of glioblastoma initiation using PDGF-AA and p53-null neural progenitors.

Authors:  Alexandra K Bohm; Jessica DePetro; Carmen E Binding; Amanda Gerber; Nicholas Chahley; N Dan Berger; Mathaeus Ware; Kaitlin Thomas; U Senapathi; Shazreh Bukhari; Cindy Chen; Erin Chahley; Cameron Grisdale; Sam Lawn; Yaping Yu; Raymond Wong; Yaoqing Shen; Hiba Omairi; Reza Mirzaei; Nourah Alshatti; Haley Pedersen; Wee Yong; Samuel Weiss; Jennifer Chan; P J Cimino; John Kelly; Steve Jones; Eric Holland; Michael Blough; Gregory Cairncross
Journal:  Neuro Oncol       Date:  2020-08-17       Impact factor: 12.300

10.  The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.

Authors:  Daniela F Quail; Robert L Bowman; Leila Akkari; Marsha L Quick; Alberto J Schuhmacher; Jason T Huse; Eric C Holland; James C Sutton; Johanna A Joyce
Journal:  Science       Date:  2016-05-20       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.